Overview

A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and efficacy of LY3009104 in participants with Rheumatoid Arthritis (RA).
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Incyte Corporation
Treatments:
Methotrexate